{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:33:05Z","timestamp":1771018385615,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11940-011-0153-6","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T10:56:01Z","timestamp":1320836161000},"page":"1-14","source":"Crossref","is-referenced-by-count":15,"title":["Menstrual Migraine: Update on Pathophysiology and Approach to Therapy and Management"],"prefix":"10.1007","volume":"14","author":[{"given":"Anne H.","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"153_CR1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0885-3924(93)90107-7","volume":"8","author":"SD Silberstein","year":"1993","unstructured":"Silberstein SD, Merriam GR. Sex hormones and headache. J Pain Symptom Manage. 1993;8:243\u201359.","journal-title":"J Pain Symptom Manage"},{"key":"153_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646\u201357.","journal-title":"Headache"},{"issue":"9","key":"153_CR3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/0333102409355601","volume":"30","author":"TW Victor","year":"2010","unstructured":"Victor TW, Hu X, Campbell JC, et al. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30(9):1065\u201372.","journal-title":"Cephalalgia"},{"issue":"suppl 136","key":"153_CR4","first-page":"1","volume":"51","author":"BS Bille","year":"1962","unstructured":"Bille BS. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Paediatr. 1962;51 suppl 136:1\u2013151.","journal-title":"Acta Paediatr"},{"key":"153_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(75)91558-5","volume":"1","author":"MT Epstein","year":"1975","unstructured":"Epstein MT, Hockaday JM, Hockaday TD. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975;1:543\u20138.","journal-title":"Lancet"},{"key":"153_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(93)90121-W","volume":"17","author":"I Neri","year":"1993","unstructured":"Neri I, Granella F, Nappi R, et al. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17:31\u20137.","journal-title":"Maturitas"},{"key":"153_CR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.53.3.537","volume":"53","author":"LJ Launer","year":"1999","unstructured":"Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology. 1999;53:537\u201342.","journal-title":"Neurology"},{"key":"153_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00023210-199912030-00003","volume":"12","author":"CL Lay","year":"1999","unstructured":"Lay CL, Newman LC. Menstrual migraine: approaches to management. CNS Drugs. 1999;12:189\u201395.","journal-title":"CNS Drugs"},{"issue":"suppl 1","key":"153_CR9","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edn. Cephalalgia. 2004;24 suppl 1:9\u2013160.","journal-title":"Cephalalgia"},{"key":"153_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1526-4610.1985.hed2507376.x","volume":"25","author":"RN Edelson","year":"1985","unstructured":"Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache. 1985;25:376\u20139.","journal-title":"Headache"},{"key":"153_CR11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1468-2982.2003.00516.x","volume":"23","author":"EG Couturier","year":"2003","unstructured":"Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia. 2003;23:302\u20138.","journal-title":"Cephalalgia"},{"key":"153_CR12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.55.10.1517","volume":"55","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Chee E, et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55:1517\u201323.","journal-title":"Neurology"},{"issue":"10","key":"153_CR13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0333102409359315","volume":"30","author":"B Pinkerman","year":"2010","unstructured":"Pinkerman B, Holroyd K. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia. 2010;30(10):1187\u201394.","journal-title":"Cephalalgia"},{"issue":"suppl 18","key":"153_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0333102497017S1805","volume":"17","author":"J Schoenen","year":"1997","unstructured":"Schoenen J, Sawyer J. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B\/1D agonist: an overview of efficacy. Cephalalgia. 1997;17 suppl 18:28\u201340.","journal-title":"Cephalalgia"},{"key":"153_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1468-2982.1999.1901016.x","volume":"19","author":"R Salonen","year":"1999","unstructured":"Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analysis. Cephalalgia. 1999;19:16\u20139.","journal-title":"Cephalalgia"},{"key":"153_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0029-7844(00)00880-2","volume":"96","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD, Massiou H, Le Jeunne C, et al. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol. 2000;96:237\u201342.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"153_CR17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1526-4610.2010.01625.x","volume":"50","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA, Victor TW, Hu X, et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010;50(4):528\u201338.","journal-title":"Headache."},{"key":"153_CR18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1526-4610.2008.01176.x","volume":"48","author":"A Calhoun","year":"2008","unstructured":"Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008;48:1186\u201393.","journal-title":"Headache"},{"key":"153_CR19","unstructured":"Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. The American Academy of Neurology. Available at: http:\/\/www.ahsnet.org\/ guidelines.php. Accessed June, 2011. This website provides a review of American Academy of Neurology guidelines for acute treatment of migraine."},{"key":"153_CR20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1526-4610.2007.00780.x","volume":"47","author":"AH Calhoun","year":"2007","unstructured":"Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47:1178\u201383.","journal-title":"Headache"},{"key":"153_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3999(03)00067-9","volume":"56","author":"FC Baker","year":"2004","unstructured":"Baker FC, Driver HS. Self-reported sleep across the menstrual cycle in young, healthy women. J Psychosom Res. 2004;56:239\u201343.","journal-title":"J Psychosom Res"},{"key":"153_CR22","unstructured":"Hollander LE, Freeman EW, Sammel MD, et al.: M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 2001;98:391\u2013397."},{"issue":"17","key":"153_CR23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000310638.54698.36","volume":"70","author":"T Pringsheim","year":"2008","unstructured":"Pringsheim T, Davenport WJ, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology. 2008;70(17):1555\u201363.","journal-title":"Neurology"},{"issue":"1","key":"153_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","volume":"114","author":"LK Mannix","year":"2009","unstructured":"Mannix LK, Martin VT, Cady RK, et al. Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol. 2009;114(1):106\u201313.","journal-title":"Obstet Gynecol."},{"key":"153_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archneur.55.2.210","volume":"55","author":"RB Lipton","year":"1998","unstructured":"Lipton RB, Stewart WF, Ryan Jr RE, et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol. 1998;55:210\u20137.","journal-title":"Arch Neurol"},{"key":"153_CR26","volume-title":"Headache in clinical practice","year":"1998","unstructured":"Silberstein SD, Lipton RB, Goadsby PJ, editors. Headache in clinical practice. Oxford: ISIS Medical Media; 1998."},{"key":"153_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1468-2982.2005.01064.x","volume":"26","author":"HC Diener","year":"2006","unstructured":"Diener HC, Montagna P, Gacs G, et al. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia. 2006;26:537\u201347.","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"153_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2165\/00003495-199300461-00031","volume":"46","author":"M Giacovazzo","year":"1993","unstructured":"Giacovazzo M, Gallo MF, Guidi V, Rico R, Scaricabarozzi I. Nimesulide in the treatment of menstrual migraine. Drugs. 1993;46 Suppl 1:140\u20131.","journal-title":"Drugs"},{"key":"153_CR29","first-page":"176","volume":"5","author":"NS Al-Waili","year":"2000","unstructured":"Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res. 2000;5:176\u201382.","journal-title":"Eur J Med Res"},{"key":"153_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00023210-200317060-00005","volume":"17","author":"AM Rapoport","year":"2003","unstructured":"Rapoport AM, Tepper SJ, Bigal ME, Sheftell FD. The triptan formulations: how to match patients and products. CNS Drugs. 2003;17:431\u201347.","journal-title":"CNS Drugs"},{"key":"153_CR31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0029-7844(03)00659-8","volume":"102","author":"R Nett","year":"2003","unstructured":"Nett R, Landy S, Shackelford S, Richardson MS, et al. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol. 2003;102:835\u201342.","journal-title":"Obstet Gynecol"},{"key":"153_CR32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1468-2982.2007.01313.x","volume":"27","author":"LK Mannix","year":"2007","unstructured":"Mannix LK, Loder E, Nett R, et al. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia. 2007;27:414\u201321.","journal-title":"Cephalalgia"},{"key":"153_CR33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00023210-200620120-00005","volume":"20","author":"M Tuchman","year":"2006","unstructured":"Tuchman M, Hee A, Emeribe U, et al. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs. 2006;20:1019\u201326.","journal-title":"CNS Drugs"},{"issue":"10","key":"153_CR34","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1468-1331.2005.01076.x","volume":"12","author":"H Massiou","year":"2005","unstructured":"Massiou H, Jamin C, Hinzelin G, et al. Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol. 2005;12(10):774\u201381.","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"153_CR35","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1007\/s10072-011-0547-y","volume":"32","author":"G Allais","year":"2011","unstructured":"Allais G, Tullo V, Benedetto C, et al. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurol Sci. 2011;32 Suppl 1:S99\u2013104.","journal-title":"Neurol Sci"},{"issue":"Suppl 2","key":"153_CR36","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1007\/s10072-006-0600-4","volume":"27","author":"G Allais","year":"2006","unstructured":"Allais G, Acuto G, Cabarrocas X, et al. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci. 2006;27 Suppl 2:S193\u2013197.","journal-title":"Neurol Sci"},{"key":"153_CR37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x","volume":"30","author":"G Sances","year":"1990","unstructured":"Sances G, Martignoni E, Fioroni L, et al. Naproxen sodium in menstrual migraine prophylaxis: a doubleblind placebo controlled study. Headache. 1990;30:705\u20139.","journal-title":"Headache"},{"issue":"Suppl 2","key":"153_CR38","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1007\/s10072-007-0783-3","volume":"28","author":"G Allais","year":"2007","unstructured":"Allais G, Bussone G, De Lorenzo C, et al. Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci. 2007;28 Suppl 2:S225\u20138.","journal-title":"Neurol Sci"},{"key":"153_CR39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1526-4610.2004.04033.x","volume":"44","author":"RL Seggern Von","year":"2004","unstructured":"Von Seggern RL, Mannix LK, Adelman JU. Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial. Headache. 2004;44:160\u20135.","journal-title":"Headache"},{"key":"153_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.51.1.307","volume":"51","author":"LC Newman","year":"1998","unstructured":"Newman LC, Lipton RB, Lay CL, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology. 1998;51:307\u20139.","journal-title":"Neurology"},{"key":"153_CR41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","volume":"41","author":"LC Newman","year":"2001","unstructured":"Newman LC, Mannix LK, Sandy S, et al. Naratriptan as short-term prophylaxis of menstrually-associated migraine: A randomized, double-blind, placebo-controlled study. Headache. 2001;41:248\u201356.","journal-title":"Headache"},{"key":"153_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","volume":"63","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261\u20139.","journal-title":"Neurology"},{"key":"153_CR43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1526-4610.2003.03007.x","volume":"43","author":"S Tepper","year":"2003","unstructured":"Tepper S, Freitag F. Prophylactic use of frovatriptan for menstrually associated migraine is effective and does not cause rebound migraine in the postdosing period (abstract). Headache. 2003;43:585.","journal-title":"Headache"},{"key":"153_CR44","first-page":"587","volume":"43","author":"R Singer","year":"2003","unstructured":"Singer R, Schim J. Frovatriptan for prophylaxis of menstrually associated migraine: efficacy and tolerability in patients using oral contraceptives compared to nonusers (abstract). Headache. 2003;43:587.","journal-title":"Headache"},{"issue":"4","key":"153_CR45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1526-4610.2010.01628.x","volume":"50","author":"DA Marcus","year":"2010","unstructured":"Marcus DA, Bernstein CD, Sullivan EA, et al. Perimenstrual eletriptan prevents menstrual migraine: an open-label study. Headache. 2010;50(4):551\u201362.","journal-title":"Headache"},{"key":"153_CR46","first-page":"38","volume":"29","author":"A Calhoun","year":"2004","unstructured":"Calhoun A. Four hypotheses for understanding menstrual migraine. The Female Patient. 2004;29:38\u201344.","journal-title":"The Female Patient"},{"key":"153_CR47","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, et al. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology. 2006;67:2159\u201363.","journal-title":"Neurology"},{"key":"153_CR48","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","volume":"293","author":"B Lignieres de","year":"1986","unstructured":"de Lignieres B, Vincens M, Mauvais-Jarvis P, et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed). 1986;293:1540.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"153_CR49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11916-009-0062-5","volume":"13","author":"AH Calhoun","year":"2009","unstructured":"Calhoun AH, Hutchinson S. Hormonal therapies for menstrual migraine. Curr Pain Headache Rep. 2009;13:381\u2013385.","journal-title":"Curr Pain Headache Rep."},{"key":"153_CR50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, Coffee A, et al. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache. 2007;47:27\u201337.","journal-title":"Headache"},{"key":"153_CR51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","volume":"348","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1996","unstructured":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:498\u2013505.","journal-title":"Lancet"},{"key":"153_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","volume":"335","author":"DB Petitti","year":"1996","unstructured":"Petitti DB, Sidney S, Bernstein A, et al. Stroke in users of low-dose oral contraceptives. N Engl J Med. 1996;335:8\u201315.","journal-title":"N Engl J Med"},{"key":"153_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.164.7.741","volume":"164","author":"WS Chan","year":"2004","unstructured":"Chan WS, Ray J, Wai EK, et al. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med. 2004;164:741\u20137.","journal-title":"Arch Intern Med"},{"key":"153_CR54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1474-4422(04)00768-9","volume":"3","author":"EA MacGregor","year":"2004","unstructured":"MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3:354\u201361.","journal-title":"Lancet Neurol"},{"key":"153_CR55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.73.6.747","volume":"73","author":"M Donaghy","year":"2002","unstructured":"Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"153_CR56","volume-title":"Extended-cycle use of a ring contraceptive may reduce frequency of migraine aura","author":"A Calhoun","year":"2011","unstructured":"Calhoun A, Ford S, Pruitt A. Extended-cycle use of a ring contraceptive may reduce frequency of migraine aura. Washington: Am Headache Soc Annual Scientific Meeting; 2011."},{"key":"153_CR57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.48.1.101","volume":"48","author":"AG Herzog","year":"1997","unstructured":"Herzog AG. Continuous bromocriptine therapy in menstrual migraine. Neurology. 1997;48:101\u20132.","journal-title":"Neurology"},{"key":"153_CR58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1526-4610.1976.hed1603109.x","volume":"16","author":"JM Hockaday","year":"1976","unstructured":"Hockaday JM, Peet KM, Hockaday TD. Bromocriptine in migraine. Headache. 1976;16:109\u201314.","journal-title":"Headache"},{"key":"153_CR59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2003.03092.x","volume":"43","author":"SJ Wang","year":"2003","unstructured":"Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache. 2003;43:470\u20138.","journal-title":"Headache"},{"key":"153_CR60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2004.04020.x","volume":"44","author":"AH Calhoun","year":"2004","unstructured":"Calhoun AH. Migraine and menopause. Headache. 2004;44:106.","journal-title":"Headache"},{"key":"153_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","volume":"31","author":"F Facchinetti","year":"1991","unstructured":"Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31:298\u2013301.","journal-title":"Headache"},{"key":"153_CR62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0753-3322(02)00181-6","volume":"56","author":"BE Burke","year":"2002","unstructured":"Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother. 2002;56:283\u20138.","journal-title":"Biomed Pharmacother"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0153-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-011-0153-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0153-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T15:18:36Z","timestamp":1713107916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-011-0153-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0153-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]}}}